Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001615219-20-000077
Filing Date
2020-07-16
Accepted
2020-07-16 08:33:50
Documents
1
Period of Report
2020-07-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_159490281747698.html 4  
1 FORM 4 wf-form4_159490281747698.xml 4 3805
  Complete submission text file 0001615219-20-000077.txt   5305
Mailing Address C/O HISTOGENICS CORPORATION 830 WINTER STREET #3 WALTHAM MA 02451
Business Address
Lieber Jonathan I (Reporting) CIK: 0001350090 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36812 | Film No.: 201030808

Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Issuer) CIK: 0001615219 (see all company filings)

EIN.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations